The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Affiliations

• ¹ School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: [email protected].
• ² School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
• ³ Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.
• ⁴ Université de Paris, Centre of Epidemiology and Statistics (CRESS), Inserm, F 75004, Paris, France.
• ⁵ Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia.
• ⁶ University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
• ⁷ Knowledge Translation Program, Li Ka Shing Knowledge Institute, Toronto, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
• ⁸ Evidence Partners, Ottawa, Canada.
• ⁹ Clinical Research Institute, American University of Beirut, Beirut, Lebanon; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
• ¹⁰ Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA.
• ¹¹ York Health Economics Consortium (YHEC Ltd), University of York, York, UK.
• ¹² Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, Canada.
• ¹³ Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, JB Winsløwsvej 9b, 3(rd) Floor, 5000 Odense, Denmark; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
• ¹⁴ Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada; Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Canada; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada.
• ¹⁵ Department of Ophthalmology, School of Medicine, University of Colorado Denver, Denver, Colorado, United State; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
• ¹⁶ Division of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Head of Research, The BMJ, London, UK.
• ¹⁷ Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.
• ¹⁸ Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
• ¹⁹ Centre for Reviews and Dissemination, University of York, York, UK.
• ²⁰ EPPI-Centre, UCL Social Research Institute, University College London, London, UK.
• ²¹ Li Ka Shing Knowledge Institute of St. Michael's Hospital, Unity Health Toronto, Toronto, Canada; Epidemiology Division of the Dalla Lana School of Public Health and the Institute of Health Management, Policy, and Evaluation, University of Toronto, Toronto, Canada; Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
• ²² Methods Centre, Bruyère Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
• ²³ Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.